Relapsed/refractory pediatric B-cell non-Hodgkin lymphoma treated with rituximab combination therapy: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group

Non-Hodgkin Lymphoma in Children and Adolescents: Progress Through Effective Collaboration, Current Knowledge, and Challenges Ahead

(2015) Véronique Minard-Colin et al.   JOURNAL OF CLINICAL ONCOLOGY

Prognostic impact of cytogenetic abnormalities in children and adolescents with mature B-cell non-Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group (JPLSG)

(2015) Masahiro Sekimizu et al.   PEDIATRIC BLOOD & CANCER

Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report

(2014) Stanton Goldman et al.   BRITISH JOURNAL OF HAEMATOLOGY

Improved treatment results of children with B-cell non-Hodgkin lymphoma: A report from the Japanese Pediatric Leukemia/Lymphoma Study Group B-NHL03 study

(2014) Masahito Tsurusawa et al.   PEDIATRIC BLOOD & CANCER

Rituximab pharmacokinetics in children and adolescents withde novointermediate and advanced mature B-cell lymphoma/leukaemia: a Children's Oncology Group report

(2013) Matthew J. Barth et al.   BRITISH JOURNAL OF HAEMATOLOGY

Advanced Stage, Increased Lactate Dehydrogenase, and Primary Site, but Not Adolescent Age (≥ 15 Years), Are Associated With an Increased Risk of Treatment Failure in Children and Adolescents With Mature B-Cell Non-Hodgkin's Lymphoma: Results of the FAB LMB 96 Study

(2012) Mitchell S. Cairo et al.   JOURNAL OF CLINICAL ONCOLOGY

Rituximab and FAB/LMB 96 chemotherapy in children with Stage III/IV B-cell non-Hodgkin lymphoma: a Children’s Oncology Group report

(2012) S Goldman et al.   LEUKEMIA

Outcome of childhood relapsed or refractory mature B-cell non-Hodgkin lymphoma and acute lymphoblastic leukemia

(2012) Parameswaran Anoop et al.   LEUKEMIA & LYMPHOMA

Autologous Peripheral Blood Stem Cell Transplantation in Children with Refractory or Relapsed Lymphoma: Results of Children’s Oncology Group Study A5962

(2010) Richard E. Harris et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Hematopoietic Stem Cell Transplantation for Refractory or Recurrent Non-Hodgkin Lymphoma in Children and Adolescents

(2009) Thomas G. Gross et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Excellent survival following two courses of COPAD chemotherapy in children and adolescents with resected localized B-cell non-Hodgkin’s lymphoma: results of the FAB/LMB 96 international study

(2008) Mary Gerrard et al.   BRITISH JOURNAL OF HAEMATOLOGY

The role of hematopoietic stem cell transplantation with relapsed or primary refractory childhood B-cell non-Hodgkin lymphoma and mature B-cell leukemia: A retrospective analysis of enrolled cases in Japan

(2008) Naoto Fujita et al.   PEDIATRIC BLOOD & CANCER

A study of rituximab and ifosfamide, carboplatin, and etoposide chemotherapy in children with recurrent/refractory B-cell (CD20+) non-Hodgkin lymphoma and mature B-cell acute lymphoblastic leukemia: A report from the Children's Oncology Group

(2008) Timothy C. Griffin et al.   PEDIATRIC BLOOD & CANCER